<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9FAEB115-B448-4CE5-A56F-A6A270B4C57A"><gtr:id>9FAEB115-B448-4CE5-A56F-A6A270B4C57A</gtr:id><gtr:name>International Federation of Gynecology and Obstetrics (FIGO)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/BC36CFCD-84DC-4562-A82B-301C5576ABBD"><gtr:id>BC36CFCD-84DC-4562-A82B-301C5576ABBD</gtr:id><gtr:name>Mwananyamala Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/7094EBEB-6F4D-46BA-A9AB-9ECF371FACED"><gtr:id>7094EBEB-6F4D-46BA-A9AB-9ECF371FACED</gtr:id><gtr:name>Karimabad Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/52F64203-E6D7-4E46-8159-AAEAD63DC27C"><gtr:id>52F64203-E6D7-4E46-8159-AAEAD63DC27C</gtr:id><gtr:name>Agha Khan Diagnostic Centre Garden</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/0F1F04B1-1E9F-4377-81C0-9E3FB3257EE5"><gtr:id>0F1F04B1-1E9F-4377-81C0-9E3FB3257EE5</gtr:id><gtr:name>UK Sepsis Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/734F19C1-61E5-45B1-A183-63FDD145328F"><gtr:id>734F19C1-61E5-45B1-A183-63FDD145328F</gtr:id><gtr:name>World Health Organization (WHO)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/975A9F33-3873-423C-AADB-77257FFD8C25"><gtr:id>975A9F33-3873-423C-AADB-77257FFD8C25</gtr:id><gtr:name>Aga Khan University</gtr:name><gtr:address><gtr:line1>Stadium Road</gtr:line1><gtr:line2>PO Box 3500</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9B4CA5C7-E2C8-4736-BF8E-46D08D8D741E"><gtr:id>9B4CA5C7-E2C8-4736-BF8E-46D08D8D741E</gtr:id><gtr:name>Center for Perinatal Studies, Rosarino (CREP)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/885DF811-29D2-42F7-AB4C-5857ED774495"><gtr:id>885DF811-29D2-42F7-AB4C-5857ED774495</gtr:id><gtr:name>Mbale Regional Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/61FDEA2B-067A-432D-9447-1A7D358CF196"><gtr:id>61FDEA2B-067A-432D-9447-1A7D358CF196</gtr:id><gtr:name>Kharader Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/AB6EAF29-9009-4D1B-A674-5C9EA1ECC8E7"><gtr:id>AB6EAF29-9009-4D1B-A674-5C9EA1ECC8E7</gtr:id><gtr:name>MedSciNet</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E532008F-9926-44BF-90FE-410040EB6E73"><gtr:id>E532008F-9926-44BF-90FE-410040EB6E73</gtr:id><gtr:name>Jhpiego</gtr:name><gtr:address><gtr:line1>1615 Thames Street</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/91FB8719-0326-4682-9C6A-ED21DA0452D0"><gtr:id>91FB8719-0326-4682-9C6A-ED21DA0452D0</gtr:id><gtr:name>Miscarriage Association</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/39332409-96B4-4437-9AD4-A410B2EC155C"><gtr:id>39332409-96B4-4437-9AD4-A410B2EC155C</gtr:id><gtr:name>National Perinatal Epidemiology Unit (NPEU)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/7D48CC7B-C97A-41EF-9EB5-2C7364F6698A"><gtr:id>7D48CC7B-C97A-41EF-9EB5-2C7364F6698A</gtr:id><gtr:name>Hospital Ram?n y Cajal</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/8446A993-B4C4-4CF7-8C31-B7F7566AA246"><gtr:id>8446A993-B4C4-4CF7-8C31-B7F7566AA246</gtr:id><gtr:name>University of Malawi</gtr:name><gtr:address><gtr:line1>P.O. Box 278</gtr:line1><gtr:line4>Zomba</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Malawi</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/7373D8EB-9402-4CD1-8C38-2796D1673E26"><gtr:id>7373D8EB-9402-4CD1-8C38-2796D1673E26</gtr:id><gtr:name>Queen Elizabeth Central Hospital, Malawi</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3ED60B49-9C2B-4D71-B644-96CCC7F10194"><gtr:id>3ED60B49-9C2B-4D71-B644-96CCC7F10194</gtr:id><gtr:name>Liverpool School of Tropical Medicine</gtr:name><gtr:address><gtr:line1>School Of Tropical Medicine</gtr:line1><gtr:line2>Pembroke Place</gtr:line2><gtr:postCode>L3 5QA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/36B4BB8C-AEBC-4512-B925-6869C40630FB"><gtr:id>36B4BB8C-AEBC-4512-B925-6869C40630FB</gtr:id><gtr:name>Ammalife</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/B81A8A77-A5ED-491B-8A8C-7CC7ACE9398D"><gtr:id>B81A8A77-A5ED-491B-8A8C-7CC7ACE9398D</gtr:id><gtr:name>Bagamoyo District Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2D7CD111-EDF3-4E37-8D86-76535AAA2D53"><gtr:id>2D7CD111-EDF3-4E37-8D86-76535AAA2D53</gtr:id><gtr:name>Ifakara Health Institute</gtr:name><gtr:address><gtr:line1>Plot 463, Kiko Avenue Mikocheni</gtr:line1><gtr:line2>P.O. Box 78373</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Tanzania, United Republic of</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Clinical and Experimental Medicine</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9FAEB115-B448-4CE5-A56F-A6A270B4C57A"><gtr:id>9FAEB115-B448-4CE5-A56F-A6A270B4C57A</gtr:id><gtr:name>International Federation of Gynecology and Obstetrics (FIGO)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/7094EBEB-6F4D-46BA-A9AB-9ECF371FACED"><gtr:id>7094EBEB-6F4D-46BA-A9AB-9ECF371FACED</gtr:id><gtr:name>Karimabad Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/0F1F04B1-1E9F-4377-81C0-9E3FB3257EE5"><gtr:id>0F1F04B1-1E9F-4377-81C0-9E3FB3257EE5</gtr:id><gtr:name>UK Sepsis Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/975A9F33-3873-423C-AADB-77257FFD8C25"><gtr:id>975A9F33-3873-423C-AADB-77257FFD8C25</gtr:id><gtr:name>Aga Khan University</gtr:name><gtr:address><gtr:line1>Stadium Road</gtr:line1><gtr:line2>PO Box 3500</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/885DF811-29D2-42F7-AB4C-5857ED774495"><gtr:id>885DF811-29D2-42F7-AB4C-5857ED774495</gtr:id><gtr:name>Mbale Regional Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E532008F-9926-44BF-90FE-410040EB6E73"><gtr:id>E532008F-9926-44BF-90FE-410040EB6E73</gtr:id><gtr:name>Jhpiego</gtr:name><gtr:address><gtr:line1>1615 Thames Street</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/39332409-96B4-4437-9AD4-A410B2EC155C"><gtr:id>39332409-96B4-4437-9AD4-A410B2EC155C</gtr:id><gtr:name>National Perinatal Epidemiology Unit (NPEU)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/7D48CC7B-C97A-41EF-9EB5-2C7364F6698A"><gtr:id>7D48CC7B-C97A-41EF-9EB5-2C7364F6698A</gtr:id><gtr:name>Hospital Ram?n y Cajal</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/8446A993-B4C4-4CF7-8C31-B7F7566AA246"><gtr:id>8446A993-B4C4-4CF7-8C31-B7F7566AA246</gtr:id><gtr:name>University of Malawi</gtr:name><gtr:address><gtr:line1>P.O. Box 278</gtr:line1><gtr:line4>Zomba</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Malawi</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/7373D8EB-9402-4CD1-8C38-2796D1673E26"><gtr:id>7373D8EB-9402-4CD1-8C38-2796D1673E26</gtr:id><gtr:name>Queen Elizabeth Central Hospital, Malawi</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/36B4BB8C-AEBC-4512-B925-6869C40630FB"><gtr:id>36B4BB8C-AEBC-4512-B925-6869C40630FB</gtr:id><gtr:name>Ammalife</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/B81A8A77-A5ED-491B-8A8C-7CC7ACE9398D"><gtr:id>B81A8A77-A5ED-491B-8A8C-7CC7ACE9398D</gtr:id><gtr:name>Bagamoyo District Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2D7CD111-EDF3-4E37-8D86-76535AAA2D53"><gtr:id>2D7CD111-EDF3-4E37-8D86-76535AAA2D53</gtr:id><gtr:name>Ifakara Health Institute</gtr:name><gtr:address><gtr:line1>Plot 463, Kiko Avenue Mikocheni</gtr:line1><gtr:line2>P.O. Box 78373</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Tanzania, United Republic of</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/BC36CFCD-84DC-4562-A82B-301C5576ABBD"><gtr:id>BC36CFCD-84DC-4562-A82B-301C5576ABBD</gtr:id><gtr:name>Mwananyamala Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/52F64203-E6D7-4E46-8159-AAEAD63DC27C"><gtr:id>52F64203-E6D7-4E46-8159-AAEAD63DC27C</gtr:id><gtr:name>Agha Khan Diagnostic Centre Garden</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/734F19C1-61E5-45B1-A183-63FDD145328F"><gtr:id>734F19C1-61E5-45B1-A183-63FDD145328F</gtr:id><gtr:name>World Health Organization (WHO)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9B4CA5C7-E2C8-4736-BF8E-46D08D8D741E"><gtr:id>9B4CA5C7-E2C8-4736-BF8E-46D08D8D741E</gtr:id><gtr:name>Center for Perinatal Studies, Rosarino (CREP)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/61FDEA2B-067A-432D-9447-1A7D358CF196"><gtr:id>61FDEA2B-067A-432D-9447-1A7D358CF196</gtr:id><gtr:name>Kharader Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AB6EAF29-9009-4D1B-A674-5C9EA1ECC8E7"><gtr:id>AB6EAF29-9009-4D1B-A674-5C9EA1ECC8E7</gtr:id><gtr:name>MedSciNet</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/91FB8719-0326-4682-9C6A-ED21DA0452D0"><gtr:id>91FB8719-0326-4682-9C6A-ED21DA0452D0</gtr:id><gtr:name>Miscarriage Association</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3ED60B49-9C2B-4D71-B644-96CCC7F10194"><gtr:id>3ED60B49-9C2B-4D71-B644-96CCC7F10194</gtr:id><gtr:name>Liverpool School of Tropical Medicine</gtr:name><gtr:address><gtr:line1>School Of Tropical Medicine</gtr:line1><gtr:line2>Pembroke Place</gtr:line2><gtr:postCode>L3 5QA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/249E2F2E-31BB-4738-A306-6B6FC303774A"><gtr:id>249E2F2E-31BB-4738-A306-6B6FC303774A</gtr:id><gtr:firstName>Metin</gtr:firstName><gtr:surname>Gulmezoglu</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/2C35A2F2-69C2-4233-8372-30BCB82491BD"><gtr:id>2C35A2F2-69C2-4233-8372-30BCB82491BD</gtr:id><gtr:firstName>Javier</gtr:firstName><gtr:surname>Zamora</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B8BCF6B9-1B50-4A85-A7A1-74A4BA28C8CE"><gtr:id>B8BCF6B9-1B50-4A85-A7A1-74A4BA28C8CE</gtr:id><gtr:firstName>Nicola Ann</gtr:firstName><gtr:surname>Desmond</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/79D9DFB7-325E-4929-B907-A767FC5E9DC1"><gtr:id>79D9DFB7-325E-4929-B907-A767FC5E9DC1</gtr:id><gtr:firstName>Lee</gtr:firstName><gtr:otherNames>Jonathan</gtr:otherNames><gtr:surname>Middleton</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/ACFA4E1A-3A47-42FC-8514-AAC511F39699"><gtr:id>ACFA4E1A-3A47-42FC-8514-AAC511F39699</gtr:id><gtr:firstName>Jane</gtr:firstName><gtr:surname>Daniels</gtr:surname><gtr:orcidId>0000-0003-3324-6771</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A1E0B3FA-2127-489C-A78C-3B32ECE1B2EE"><gtr:id>A1E0B3FA-2127-489C-A78C-3B32ECE1B2EE</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Lissauer</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/CB391EC7-E9D7-4E64-83CE-116B13B009BB"><gtr:id>CB391EC7-E9D7-4E64-83CE-116B13B009BB</gtr:id><gtr:firstName>godfrey</gtr:firstName><gtr:otherNames>michael</gtr:otherNames><gtr:surname>mbaruku</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/3E3F2272-052B-4E50-8CB0-70EBB5A24160"><gtr:id>3E3F2272-052B-4E50-8CB0-70EBB5A24160</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>Weeks</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/1783E832-4F52-47C3-BBC8-095E03804CF6"><gtr:id>1783E832-4F52-47C3-BBC8-095E03804CF6</gtr:id><gtr:firstName>Olufemi</gtr:firstName><gtr:surname>Oladapo</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/65B4EC91-E58F-4420-8EBD-2F47488868DD"><gtr:id>65B4EC91-E58F-4420-8EBD-2F47488868DD</gtr:id><gtr:firstName>Arri</gtr:firstName><gtr:otherNames>Aravinthan</gtr:otherNames><gtr:surname>Coomarasamy</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F2AF8E81-B2C1-4C3E-944F-2F9FD94E8744"><gtr:id>F2AF8E81-B2C1-4C3E-944F-2F9FD94E8744</gtr:id><gtr:firstName>Bonus</gtr:firstName><gtr:otherNames>Steven</gtr:otherNames><gtr:surname>Makanani</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=MR%2FK007408%2F1"><gtr:id>171B06D3-26EA-4C7E-84E4-FD552BC423EF</gtr:id><gtr:title>Effectiveness of antibiotic prophylaxis during surgical evacuation of the uterus for miscarriage management in low income countries. (AIMS Trial)</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/K007408/1</gtr:grantReference><gtr:abstractText>Infection following miscarriage surgery - A GLOBAL PROBLEM:
Globally, 210 million women become pregnant each year, but 33 million of these pregnancies end in a miscarriage. A majority of women with a miscarriage will have surgery. In low income settings, the infection rate after miscarriage surgery has been reported to be as high as 30%. Infection after miscarriage can result in serious illness and death, as well as long term consequences including increased rates of ectopic pregnancy, infertility and persistent pain.

Prophylactic antibiotics - A POTENTIAL SOLUTION:
Prophylactic antibiotics, given before surgery, may improve outcomes. However, for miscarriage surgery, current guidelines from the WHO, UK national guidelines, and national guidelines from low income countries do not recommend prophylactic antibiotics. This is because of limited evidence. We propose that prophylactic antibiotics, used at the time of surgery, may offer a solution to reducing the serious problem of infection following miscarriage.

The existing evidence - A TRIAL IS NEEDED:
A recent review of all the evidence concluded that &amp;quot;there is not enough evidence to evaluate a policy of routine antibiotic prophylaxis to women with incomplete miscarriage&amp;quot; and &amp;quot;There is a real and urgent need to find out whether antibiotics should be routinely used in cases of incomplete miscarriage. The policy and cost implications arising from this research will be tremendous, and randomised clinical trials comparing antibiotics currently in use with no antibiotics are strongly recommended.&amp;quot;

The proposed AIMS trial:
The question: Can pelvic infection after miscarriage surgery be reduced by giving antibiotics to women just before surgery?
Study sites: The study will be conducted in 3 countries in Sub-Saharan Africa; Tanzania, Malawi and Uganda. These countries have been chosen as women have the greatest problems with infection after miscarriage in low income countries and this is therefore the place where this research could have the greatest impact to improve health.
What the trial involves: Women having surgery for miscarriage will be invited to participate, and if consent is given, women will be offered a single dose of antibiotics, to be taken by mouth two hours before the surgery. We plan to recruit 2400 women in total over 2 years.
The treatment given will be either antibiotics (400mg doxycycline and 400mg metronidazole) or a dummy pill (placebo). The women and clinician will not know if the tablet is the antibiotic or the dummy pill. By comparing the rate of infection and other problems such as death or admission to hospital during the first 2 weeks after surgery between the groups we can determine if the antibiotics are having any effect. Any women in whom an infection is found will have appropriate treatment and also further tests to identify the cause of the infection.

Clinician support for the trial:
The trial is endorsed by international professional organisations and a survey of 124 practitioners from 23 low income countries overwhelmingly (87.5%) supported the need for the AIMS trial.

User support and acceptability:
Semi-structured interviews with gynaecology inpatients in Blantyre, Malawi and Mbale, Uganda showed there was recognition of the potential problems following miscarriage and that the proposed protocol was acceptable. Participants indicated they would be willing to participate and return for follow up assessments. The trial has also been endorsed by the patient group the Miscarriage Association.

The potential benefits of the trial:
Miscarriage surgery is common, and infective complications are frequent and serious. Prophylactic antibiotics, if found effective, may offer a simple and affordable intervention which could be rapidly implemented to reduce the burden of maternal mortality and disease in low income countries. This may directly address MDG5 (reducing maternal mortality), where progress has been uneven and slow.</gtr:abstractText><gtr:technicalSummary>Objective: To evaluate the effects of prophylactic antibiotics (Doxycycline 400mg and metronidazole 400mg, given orally, as a single dose prior to surgery) in women undergoing surgical management of miscarriage in low income countries, with the primary outcome of pelvic infection.

Short title: The AIMS (Antibiotics in Miscarriage Surgery) Trial

Study design:
Randomised, double-blind, placebo-controlled, multicentre, multi-national trial. Unit of randomisation is at the individual patient level.

Study duration:
36 months.

Research sites:
a) Malawi: Queen Elizabeth Central Hospital, Blantyre.
b) Uganda: Mbale Regional Hospital.
c) Tanzania: St Francis Hospital (Ifakara) and Bagamoyo District Hospital.
Trial sponsorship:
University of Birmingham

Trial management:
Jointly hosted by University of Birmingham Clinical Trials Unit (BCTU) and College of Medicine, Blantyre, Vaccine &amp;amp; Clinical Trials Unit (VCTU).

Population:
Women undergoing surgical evacuation of the uterus for miscarriage management are eligible to take part in the study.

Intervention:
Doxycycline 400mg oral and Metronidazole 400mg oral, as single dose, taken 2 hours before surgery.

Control:
Identical placebo

Randomisation:
Computerised third-party randomisation with allocation concealment. 

Primary outcome:
Pelvic infection within 14 days of surgery, defined as two or more of a) purulent vaginal discharge, b) pyrexia &amp;gt;38.0, c) uterine tenderness, and d) a white cell count &amp;gt;15x109 /l.

Sample size:
To randomise 2400 women (Will give 90% power at p=0.05 to detect a 4% reduction in absolute risk of pelvic infection from a baseline risk of 10% (a relative risk of 0.6, based on our systematic review of antibiotic prophylaxis in induced abortion surgery)).

Dissemination:
By publication of findings and dissemination through FIGO, WHO, RCOG, National societies, dissemination meetings in all countries and the study website. We will also update the Cochrane review</gtr:technicalSummary><gtr:potentialImpactText>If antibiotic prophylaxis is found to be a successful strategy then the principal beneficiaries will be women in low income countries who could be offered this treatment and in future will be at a reduced risk of infection after miscarriage surgery. This could reduce the occurrence of sepsis in these women, thus reducing serious illness, organ failure and death. It may also reduce serious long term complications such as ectopic pregnancy, subfertility and chronic pelvic pain.

Miscarriage and miscarriage surgery are so common (20 million procedures worldwide annually) that this would be a very important finding, with the potential to have a major impact on maternal health. Furthermore, as this is a simple and inexpensive intervention we would expect that our dissemination plan could lead to it being widely and rapidly implemented, with national and international guidelines changed, and clinicians altering their practice. Miscarriage and miscarriage surgery are so common, that it places a major burden on national budgets for maternal health. Reducing post miscarriage complications could therefore lead to increased resources available for other women's health services. If the use of prophylactic antibiotics is not found to be successful then our dissemination plan would similarly ensure that women were not unnecessarily exposed to antibiotics and that health systems were not spending on an unnecessary treatment.

Women recruited to the trial will benefit from the peer support groups established, the provision of the complete World Health Organsiation post abortal care package and careful follow-up during the post operative period, which will ensure any complications are recognised early and treated appropriately. Women with miscarriage at the participating hospitals even if they choose not to participate will benefit from the peer support groups and enhanced training of staff in miscarriage care. We hope to inspire a change in organisational culture with a renewed focus on this important problem. We hope this legacy will last beyond the trial and positively benefit all women with miscarriage in these units.

Staff employed in Africa will be recruited with sensitivity to the need not to distort local health economies or reduce the availability of clinical staff. There will be an emphasis on local capacity building and professional development of these individuals. This will include training, mentorship and active participation in the research process. The particular need for capacity building of the Malawi Vaccine and Trials Unit has been identified and additional money has therefore been sought to support this requirement and also funds for an African trial coordinator at this site, working alongside staff at the Birmingham Clinical Trials Unit have been requested. The trial management structure (Figure 7) uses local trial management organisations not only to maximise efficiency but also to support the need to build local clinical trials capacity.</gtr:potentialImpactText><gtr:fund><gtr:end>2017-08-09</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-06-10</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1464821</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs><gtr:artisticAndCreativeProductOutput><gtr:description>This film introduces and explains the importance of the AIMS trial. With a storyboard of pictures from Malawi, Tanzania and Uganda, the video features participating researchers and representatives of supporting organisations working together to evaluate the effects of prophylactic antibiotics in the surgical management of miscarriage in low income countries.</gtr:description><gtr:id>6F29FA00-7949-47EB-951A-C9DA7EC86599</gtr:id><gtr:impact>The film enables a non-specialist audience to understand the urgent requirement for more effective treatments to support miscarriage surgery.</gtr:impact><gtr:title>AIMS</gtr:title><gtr:type>Film/Video/Animation</gtr:type><gtr:url>https://m.youtube.com/watch?v=xnc22b_ef_s</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput></gtr:artisticAndCreativeProductOutputs><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>World Health Organization (WHO)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:department>Department of Reproductive Health and Research</gtr:department><gtr:description>AIMS</gtr:description><gtr:id>00764485-3FF0-49C0-98D4-9320D553602A</gtr:id><gtr:impact>More than 1600 women have been recruited to the trial. Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>The AIMS trial is being conducted at sites in Malawi, Uganda, Tanzania and Pakistan, with support and guidance from the University of Liverpool, the Liverpool School of Tropical Medicine, the Ifakara Institute of Health and the World Health Organisation. Ammalife contributes specialist expertise in the dissemination of outputs, MedSciNet UK provides data collection and management support, and the Miscarriage Association brings experience in ensuring public and patient involvement.</gtr:partnerContribution><gtr:piContribution>My research team is leading, administering and otherwise co-ordinating the AIMS trial to evaluate the effects of prophylactic antibiotics in the surgical management of miscarriage in low income countries, considering the primary outcome of pelvic infection.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ammalife</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>AIMS</gtr:description><gtr:id>52EE6485-AB53-44A1-8630-42BB0EA2A078</gtr:id><gtr:impact>More than 1600 women have been recruited to the trial. Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>The AIMS trial is being conducted at sites in Malawi, Uganda, Tanzania and Pakistan, with support and guidance from the University of Liverpool, the Liverpool School of Tropical Medicine, the Ifakara Institute of Health and the World Health Organisation. Ammalife contributes specialist expertise in the dissemination of outputs, MedSciNet UK provides data collection and management support, and the Miscarriage Association brings experience in ensuring public and patient involvement.</gtr:partnerContribution><gtr:piContribution>My research team is leading, administering and otherwise co-ordinating the AIMS trial to evaluate the effects of prophylactic antibiotics in the surgical management of miscarriage in low income countries, considering the primary outcome of pelvic infection.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Perinatal Epidemiology Unit (NPEU)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Maternal and Newborn Sepsis</gtr:description><gtr:id>93D81891-F96A-4C50-9E3B-93868B0F05B6</gtr:id><gtr:impact>Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>With our collaborative partners, we aim to build global consensus on key issues such as the definition of maternal sepsis and its validation in low and middle income countries. We also aim to strengthen international communities of healthcare professionals and researchers with expertise of relevance to maternal sepsis.</gtr:partnerContribution><gtr:piContribution>My team collaborates internationally to raise awareness of maternal and newborn sepsis, and to develop effective diagnostic tools and management strategies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Agha Khan Diagnostic Centre Garden</gtr:collaboratingOrganisation><gtr:country>Pakistan, Islamic Republic of</gtr:country><gtr:description>AIMS</gtr:description><gtr:id>ADE7A7AC-FF53-4D51-A4EC-574EA2C110BE</gtr:id><gtr:impact>More than 1600 women have been recruited to the trial. Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>The AIMS trial is being conducted at sites in Malawi, Uganda, Tanzania and Pakistan, with support and guidance from the University of Liverpool, the Liverpool School of Tropical Medicine, the Ifakara Institute of Health and the World Health Organisation. Ammalife contributes specialist expertise in the dissemination of outputs, MedSciNet UK provides data collection and management support, and the Miscarriage Association brings experience in ensuring public and patient involvement.</gtr:partnerContribution><gtr:piContribution>My research team is leading, administering and otherwise co-ordinating the AIMS trial to evaluate the effects of prophylactic antibiotics in the surgical management of miscarriage in low income countries, considering the primary outcome of pelvic infection.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Miscarriage Association</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>AIMS</gtr:description><gtr:id>720823F3-91D6-429E-8C50-F9C0D43E7F0F</gtr:id><gtr:impact>More than 1600 women have been recruited to the trial. Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>The AIMS trial is being conducted at sites in Malawi, Uganda, Tanzania and Pakistan, with support and guidance from the University of Liverpool, the Liverpool School of Tropical Medicine, the Ifakara Institute of Health and the World Health Organisation. Ammalife contributes specialist expertise in the dissemination of outputs, MedSciNet UK provides data collection and management support, and the Miscarriage Association brings experience in ensuring public and patient involvement.</gtr:partnerContribution><gtr:piContribution>My research team is leading, administering and otherwise co-ordinating the AIMS trial to evaluate the effects of prophylactic antibiotics in the surgical management of miscarriage in low income countries, considering the primary outcome of pelvic infection.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hospital Ram?n y Cajal</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:department>Clinical Biostatistics Unit</gtr:department><gtr:description>AIMS</gtr:description><gtr:id>7495D96E-F2E3-40CF-A6CC-1E3D309FEA11</gtr:id><gtr:impact>More than 1600 women have been recruited to the trial. Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>The AIMS trial is being conducted at sites in Malawi, Uganda, Tanzania and Pakistan, with support and guidance from the University of Liverpool, the Liverpool School of Tropical Medicine, the Ifakara Institute of Health and the World Health Organisation. Ammalife contributes specialist expertise in the dissemination of outputs, MedSciNet UK provides data collection and management support, and the Miscarriage Association brings experience in ensuring public and patient involvement.</gtr:partnerContribution><gtr:piContribution>My research team is leading, administering and otherwise co-ordinating the AIMS trial to evaluate the effects of prophylactic antibiotics in the surgical management of miscarriage in low income countries, considering the primary outcome of pelvic infection.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mwananyamala Hospital</gtr:collaboratingOrganisation><gtr:country>Tanzania, United Republic of</gtr:country><gtr:description>AIMS</gtr:description><gtr:id>F813D2AC-EE85-46E9-91A9-0066F30CF0FE</gtr:id><gtr:impact>More than 1600 women have been recruited to the trial. Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>The AIMS trial is being conducted at sites in Malawi, Uganda, Tanzania and Pakistan, with support and guidance from the University of Liverpool, the Liverpool School of Tropical Medicine, the Ifakara Institute of Health and the World Health Organisation. Ammalife contributes specialist expertise in the dissemination of outputs, MedSciNet UK provides data collection and management support, and the Miscarriage Association brings experience in ensuring public and patient involvement.</gtr:partnerContribution><gtr:piContribution>My research team is leading, administering and otherwise co-ordinating the AIMS trial to evaluate the effects of prophylactic antibiotics in the surgical management of miscarriage in low income countries, considering the primary outcome of pelvic infection.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ifakara Health Institute</gtr:collaboratingOrganisation><gtr:country>Tanzania, United Republic of</gtr:country><gtr:description>AIMS</gtr:description><gtr:id>9AE15E68-218C-43A6-8A21-8FFA27807139</gtr:id><gtr:impact>More than 1600 women have been recruited to the trial. Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>The AIMS trial is being conducted at sites in Malawi, Uganda, Tanzania and Pakistan, with support and guidance from the University of Liverpool, the Liverpool School of Tropical Medicine, the Ifakara Institute of Health and the World Health Organisation. Ammalife contributes specialist expertise in the dissemination of outputs, MedSciNet UK provides data collection and management support, and the Miscarriage Association brings experience in ensuring public and patient involvement.</gtr:partnerContribution><gtr:piContribution>My research team is leading, administering and otherwise co-ordinating the AIMS trial to evaluate the effects of prophylactic antibiotics in the surgical management of miscarriage in low income countries, considering the primary outcome of pelvic infection.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Kharader Hospital</gtr:collaboratingOrganisation><gtr:country>Pakistan, Islamic Republic of</gtr:country><gtr:description>AIMS</gtr:description><gtr:id>AABE7FB9-162E-4EDA-8E8A-3579D4577BE1</gtr:id><gtr:impact>More than 1600 women have been recruited to the trial. Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>The AIMS trial is being conducted at sites in Malawi, Uganda, Tanzania and Pakistan, with support and guidance from the University of Liverpool, the Liverpool School of Tropical Medicine, the Ifakara Institute of Health and the World Health Organisation. Ammalife contributes specialist expertise in the dissemination of outputs, MedSciNet UK provides data collection and management support, and the Miscarriage Association brings experience in ensuring public and patient involvement.</gtr:partnerContribution><gtr:piContribution>My research team is leading, administering and otherwise co-ordinating the AIMS trial to evaluate the effects of prophylactic antibiotics in the surgical management of miscarriage in low income countries, considering the primary outcome of pelvic infection.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Aga Khan University, Karachi</gtr:collaboratingOrganisation><gtr:country>Pakistan, Islamic Republic of</gtr:country><gtr:description>Maternal and Newborn Sepsis</gtr:description><gtr:id>78D658E8-B254-4A62-9292-B029265D8137</gtr:id><gtr:impact>Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>With our collaborative partners, we aim to build global consensus on key issues such as the definition of maternal sepsis and its validation in low and middle income countries. We also aim to strengthen international communities of healthcare professionals and researchers with expertise of relevance to maternal sepsis.</gtr:partnerContribution><gtr:piContribution>My team collaborates internationally to raise awareness of maternal and newborn sepsis, and to develop effective diagnostic tools and management strategies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Aberdeen</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Maternal and Newborn Sepsis</gtr:description><gtr:id>C72D5681-5906-4B95-AEFD-CA7A9217B1BE</gtr:id><gtr:impact>Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>With our collaborative partners, we aim to build global consensus on key issues such as the definition of maternal sepsis and its validation in low and middle income countries. We also aim to strengthen international communities of healthcare professionals and researchers with expertise of relevance to maternal sepsis.</gtr:partnerContribution><gtr:piContribution>My team collaborates internationally to raise awareness of maternal and newborn sepsis, and to develop effective diagnostic tools and management strategies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Elizabeth Central Hospital, Malawi</gtr:collaboratingOrganisation><gtr:country>Malawi, Republic of</gtr:country><gtr:description>AIMS</gtr:description><gtr:id>A27549C4-6D36-49EA-99BC-6C6C02BD71BD</gtr:id><gtr:impact>More than 1600 women have been recruited to the trial. Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>The AIMS trial is being conducted at sites in Malawi, Uganda, Tanzania and Pakistan, with support and guidance from the University of Liverpool, the Liverpool School of Tropical Medicine, the Ifakara Institute of Health and the World Health Organisation. Ammalife contributes specialist expertise in the dissemination of outputs, MedSciNet UK provides data collection and management support, and the Miscarriage Association brings experience in ensuring public and patient involvement.</gtr:partnerContribution><gtr:piContribution>My research team is leading, administering and otherwise co-ordinating the AIMS trial to evaluate the effects of prophylactic antibiotics in the surgical management of miscarriage in low income countries, considering the primary outcome of pelvic infection.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Liverpool School of Tropical Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>International Health</gtr:department><gtr:description>AIMS</gtr:description><gtr:id>6048BFBF-AAF7-458E-8F50-EC5DE201F30E</gtr:id><gtr:impact>More than 1600 women have been recruited to the trial. Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>The AIMS trial is being conducted at sites in Malawi, Uganda, Tanzania and Pakistan, with support and guidance from the University of Liverpool, the Liverpool School of Tropical Medicine, the Ifakara Institute of Health and the World Health Organisation. Ammalife contributes specialist expertise in the dissemination of outputs, MedSciNet UK provides data collection and management support, and the Miscarriage Association brings experience in ensuring public and patient involvement.</gtr:partnerContribution><gtr:piContribution>My research team is leading, administering and otherwise co-ordinating the AIMS trial to evaluate the effects of prophylactic antibiotics in the surgical management of miscarriage in low income countries, considering the primary outcome of pelvic infection.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bagamoyo District Hospital</gtr:collaboratingOrganisation><gtr:country>Tanzania, United Republic of</gtr:country><gtr:description>AIMS</gtr:description><gtr:id>8DECA0E0-3085-47E4-8C97-B81D082431F2</gtr:id><gtr:impact>More than 1600 women have been recruited to the trial. Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>The AIMS trial is being conducted at sites in Malawi, Uganda, Tanzania and Pakistan, with support and guidance from the University of Liverpool, the Liverpool School of Tropical Medicine, the Ifakara Institute of Health and the World Health Organisation. Ammalife contributes specialist expertise in the dissemination of outputs, MedSciNet UK provides data collection and management support, and the Miscarriage Association brings experience in ensuring public and patient involvement.</gtr:partnerContribution><gtr:piContribution>My research team is leading, administering and otherwise co-ordinating the AIMS trial to evaluate the effects of prophylactic antibiotics in the surgical management of miscarriage in low income countries, considering the primary outcome of pelvic infection.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>AIMS</gtr:description><gtr:id>84B031E9-C74E-45DE-B30C-1D9A582F42DA</gtr:id><gtr:impact>More than 1600 women have been recruited to the trial. Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>The AIMS trial is being conducted at sites in Malawi, Uganda, Tanzania and Pakistan, with support and guidance from the University of Liverpool, the Liverpool School of Tropical Medicine, the Ifakara Institute of Health and the World Health Organisation. Ammalife contributes specialist expertise in the dissemination of outputs, MedSciNet UK provides data collection and management support, and the Miscarriage Association brings experience in ensuring public and patient involvement.</gtr:partnerContribution><gtr:piContribution>My research team is leading, administering and otherwise co-ordinating the AIMS trial to evaluate the effects of prophylactic antibiotics in the surgical management of miscarriage in low income countries, considering the primary outcome of pelvic infection.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>St George's University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Maternal and Newborn Sepsis</gtr:description><gtr:id>5B425879-8D13-4B5C-87D6-415126A31270</gtr:id><gtr:impact>Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>With our collaborative partners, we aim to build global consensus on key issues such as the definition of maternal sepsis and its validation in low and middle income countries. We also aim to strengthen international communities of healthcare professionals and researchers with expertise of relevance to maternal sepsis.</gtr:partnerContribution><gtr:piContribution>My team collaborates internationally to raise awareness of maternal and newborn sepsis, and to develop effective diagnostic tools and management strategies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Federation of Gynecology and Obstetrics (FIGO)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Maternal and Newborn Sepsis</gtr:description><gtr:id>BCD097EB-97AE-4B13-A396-02FC5F95BDA1</gtr:id><gtr:impact>Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>With our collaborative partners, we aim to build global consensus on key issues such as the definition of maternal sepsis and its validation in low and middle income countries. We also aim to strengthen international communities of healthcare professionals and researchers with expertise of relevance to maternal sepsis.</gtr:partnerContribution><gtr:piContribution>My team collaborates internationally to raise awareness of maternal and newborn sepsis, and to develop effective diagnostic tools and management strategies.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Aga Khan University, Karachi</gtr:collaboratingOrganisation><gtr:country>Pakistan, Islamic Republic of</gtr:country><gtr:description>AIMS</gtr:description><gtr:id>6525E719-3DA0-45BE-940A-296FAC6A0F0A</gtr:id><gtr:impact>More than 1600 women have been recruited to the trial. Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>The AIMS trial is being conducted at sites in Malawi, Uganda, Tanzania and Pakistan, with support and guidance from the University of Liverpool, the Liverpool School of Tropical Medicine, the Ifakara Institute of Health and the World Health Organisation. Ammalife contributes specialist expertise in the dissemination of outputs, MedSciNet UK provides data collection and management support, and the Miscarriage Association brings experience in ensuring public and patient involvement.</gtr:partnerContribution><gtr:piContribution>My research team is leading, administering and otherwise co-ordinating the AIMS trial to evaluate the effects of prophylactic antibiotics in the surgical management of miscarriage in low income countries, considering the primary outcome of pelvic infection.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Malawi</gtr:collaboratingOrganisation><gtr:country>Malawi, Republic of</gtr:country><gtr:department>College of Medicine</gtr:department><gtr:description>AIMS</gtr:description><gtr:id>6251B1AE-462F-4321-BC50-DE8FAB69499A</gtr:id><gtr:impact>More than 1600 women have been recruited to the trial. Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>The AIMS trial is being conducted at sites in Malawi, Uganda, Tanzania and Pakistan, with support and guidance from the University of Liverpool, the Liverpool School of Tropical Medicine, the Ifakara Institute of Health and the World Health Organisation. Ammalife contributes specialist expertise in the dissemination of outputs, MedSciNet UK provides data collection and management support, and the Miscarriage Association brings experience in ensuring public and patient involvement.</gtr:partnerContribution><gtr:piContribution>My research team is leading, administering and otherwise co-ordinating the AIMS trial to evaluate the effects of prophylactic antibiotics in the surgical management of miscarriage in low income countries, considering the primary outcome of pelvic infection.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Jhpiego</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Maternal and Newborn Sepsis</gtr:description><gtr:id>3CE50036-4B5A-4581-9D0C-25AC12E0FC8D</gtr:id><gtr:impact>Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>With our collaborative partners, we aim to build global consensus on key issues such as the definition of maternal sepsis and its validation in low and middle income countries. We also aim to strengthen international communities of healthcare professionals and researchers with expertise of relevance to maternal sepsis.</gtr:partnerContribution><gtr:piContribution>My team collaborates internationally to raise awareness of maternal and newborn sepsis, and to develop effective diagnostic tools and management strategies.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MedSciNet</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>AIMS</gtr:description><gtr:id>34D48C7B-9D78-4D56-9452-35F1C573E769</gtr:id><gtr:impact>More than 1600 women have been recruited to the trial. Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>The AIMS trial is being conducted at sites in Malawi, Uganda, Tanzania and Pakistan, with support and guidance from the University of Liverpool, the Liverpool School of Tropical Medicine, the Ifakara Institute of Health and the World Health Organisation. Ammalife contributes specialist expertise in the dissemination of outputs, MedSciNet UK provides data collection and management support, and the Miscarriage Association brings experience in ensuring public and patient involvement.</gtr:partnerContribution><gtr:piContribution>My research team is leading, administering and otherwise co-ordinating the AIMS trial to evaluate the effects of prophylactic antibiotics in the surgical management of miscarriage in low income countries, considering the primary outcome of pelvic infection.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karimabad Hospital</gtr:collaboratingOrganisation><gtr:country>Pakistan, Islamic Republic of</gtr:country><gtr:description>AIMS</gtr:description><gtr:id>87BBEB86-E732-4EBF-B110-2CB6F229BF63</gtr:id><gtr:impact>More than 1600 women have been recruited to the trial. Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>The AIMS trial is being conducted at sites in Malawi, Uganda, Tanzania and Pakistan, with support and guidance from the University of Liverpool, the Liverpool School of Tropical Medicine, the Ifakara Institute of Health and the World Health Organisation. Ammalife contributes specialist expertise in the dissemination of outputs, MedSciNet UK provides data collection and management support, and the Miscarriage Association brings experience in ensuring public and patient involvement.</gtr:partnerContribution><gtr:piContribution>My research team is leading, administering and otherwise co-ordinating the AIMS trial to evaluate the effects of prophylactic antibiotics in the surgical management of miscarriage in low income countries, considering the primary outcome of pelvic infection.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mbale Regional Hospital</gtr:collaboratingOrganisation><gtr:country>Uganda, Republic of</gtr:country><gtr:description>AIMS</gtr:description><gtr:id>BFA93349-1B4D-4879-9AF3-9F7493192753</gtr:id><gtr:impact>More than 1600 women have been recruited to the trial. Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>The AIMS trial is being conducted at sites in Malawi, Uganda, Tanzania and Pakistan, with support and guidance from the University of Liverpool, the Liverpool School of Tropical Medicine, the Ifakara Institute of Health and the World Health Organisation. Ammalife contributes specialist expertise in the dissemination of outputs, MedSciNet UK provides data collection and management support, and the Miscarriage Association brings experience in ensuring public and patient involvement.</gtr:partnerContribution><gtr:piContribution>My research team is leading, administering and otherwise co-ordinating the AIMS trial to evaluate the effects of prophylactic antibiotics in the surgical management of miscarriage in low income countries, considering the primary outcome of pelvic infection.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Center for Perinatal Studies, Rosarino (CREP)</gtr:collaboratingOrganisation><gtr:country>Argentina, Argentine Republic</gtr:country><gtr:description>Maternal and Newborn Sepsis</gtr:description><gtr:id>5DF5C7FC-0D35-481D-8E1F-55CE80A7996C</gtr:id><gtr:impact>Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>With our collaborative partners, we aim to build global consensus on key issues such as the definition of maternal sepsis and its validation in low and middle income countries. We also aim to strengthen international communities of healthcare professionals and researchers with expertise of relevance to maternal sepsis.</gtr:partnerContribution><gtr:piContribution>My team collaborates internationally to raise awareness of maternal and newborn sepsis, and to develop effective diagnostic tools and management strategies.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>UK Sepsis Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Maternal and Newborn Sepsis</gtr:description><gtr:id>EB969AF5-B3F4-4510-BC0C-E4E00C8DE138</gtr:id><gtr:impact>Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>With our collaborative partners, we aim to build global consensus on key issues such as the definition of maternal sepsis and its validation in low and middle income countries. We also aim to strengthen international communities of healthcare professionals and researchers with expertise of relevance to maternal sepsis.</gtr:partnerContribution><gtr:piContribution>My team collaborates internationally to raise awareness of maternal and newborn sepsis, and to develop effective diagnostic tools and management strategies.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>AIMS</gtr:description><gtr:id>4BBB97F7-48BE-48B2-B1CD-258ABDC1EB50</gtr:id><gtr:impact>More than 1600 women have been recruited to the trial. Outputs are expected in the coming years.</gtr:impact><gtr:partnerContribution>The AIMS trial is being conducted at sites in Malawi, Uganda, Tanzania and Pakistan, with support and guidance from the University of Liverpool, the Liverpool School of Tropical Medicine, the Ifakara Institute of Health and the World Health Organisation. Ammalife contributes specialist expertise in the dissemination of outputs, MedSciNet UK provides data collection and management support, and the Miscarriage Association brings experience in ensuring public and patient involvement.</gtr:partnerContribution><gtr:piContribution>My research team is leading, administering and otherwise co-ordinating the AIMS trial to evaluate the effects of prophylactic antibiotics in the surgical management of miscarriage in low income countries, considering the primary outcome of pelvic infection.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Meeting of Collaborators: Inauguration - AIMS</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>141AB99E-3983-4158-8D5E-C42E94B20723</gtr:id><gtr:impact>The AIMS Inauguration Meeting in early November 2013 brought together researchers from three different continents to learn about one another, to develop the study database and share ideas to facilitate the project.

The AIMS Inauguration Meeting in early November 2013 consolidated teamwork and enabled researchers to prepare audiovisual material to promote the Trial.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Soda and Snacks - AIMS</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>0FA0300D-7F5A-470E-8E24-299B6A4EC2B9</gtr:id><gtr:impact>All relevant practitioners at AIMS hospitals and referral centres are periodically invited to discuss the trial informally over &amp;quot;soda and snacks.&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Ammalife - AIMS</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EA34591D-C30A-4161-8BD5-92BE996A5A29</gtr:id><gtr:impact>Ammalife is disseminating AIMS news to the public via the charity website and other events.

Lay communities are aware and informed about the AIMS Trial.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.ammalife.org/research/aims-antibiotics-in-miscarriage-surgery</gtr:url><gtr:year>2013,2014,2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>GLOW 2012 - AIMS</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7B08CC39-D3F8-491A-B549-C7828EA0BE80</gtr:id><gtr:impact>Over 100 scientists, doctors, nurses, educators, health promoters, community activists and volunteers interested in achieving safe motherhood attended the first GLOW (Global Women's Health Research Society) Conference in Liverpool on Tuesday 23 October 2012. I (Arri Coomarasamy) co-authored and co-presented a poster entitled Maximising Participant Retention In Maternal Health Trials In Low- And Lower-Middle-Income Countries: A Mixed Methods Study (with colleagues Susannah Waite and David Lissauer). This feature introduced the AIMS trial.

Delegates learned about the work of AIMS and engaged in discussions with the project team.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.glowconference.org/glow-2012.html</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Newsletters - AIMS</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5FE54B3B-4012-42A5-B151-A328D522204C</gtr:id><gtr:impact>Newsletters featuring components such as randomisation rankings, AIMS stars and FAQs are issued regularly (every two months) to participants and researchers in the AIMS trial, to keep everybody abreast of progress and build staff morale.

Collaborators have expressed appreciation of newsletters and researchers have engaged in friendly competition in rates of recruitment between sites, boosting our overall rate of progress. The FAQs of our newsletters are helping researchers and midwives to learn from the practical challenges experienced by peers.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Study participants or study members</gtr:primaryAudience><gtr:url>http://www.aimstrial.org</gtr:url><gtr:year>2014,2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Participant Contact - AIMS</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A7EEE142-9D69-4854-A572-7AAEEF899137</gtr:id><gtr:impact>Our researchers in Malawi have conducted home visits and meetings to gain a better understanding of the challenges for participants to keep follow up appointments.

Our improved understanding of the reasons for participants to decline or abandon the protocol enables our work together to better address and overcome these issues.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Study participants or study members</gtr:primaryAudience><gtr:year>2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>GLOW 2013 - AIMS</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>14F7A0AF-5D50-4E1F-8EB8-2726398D9503</gtr:id><gtr:impact>Over 100 scientists, doctors, nurses, educators, health promoters, community activists and volunteers interested in achieving safe motherhood attended the second GLOW (Global Women's Health Research Society) Conference in Birmingham on Friday 1 November 2013. This event enabled our team to disseminate news and promote the AIMS project.

Delegates learned about the work of AIMS and engaged in discussions with the project team.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.glowconference.org/glow-2013.html</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MAOCO - AIMS</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E9603756-445E-4889-8444-CBD71666C8C9</gtr:id><gtr:impact>Over time AIMS team members have inspired, supported and encouraged the professional motivation and self-belief of clinical officers in Malawi, and this cadre of healthcare workers has now established a professional development society (the Malawi Association of Obstetric Clinical Officers, MAOCO) for the purpose of sharing knowledge and expertise.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation - Maternal Sepsis February 2016 (Geneva)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B9FC5636-AEDA-4D31-B2C0-9526F769F005</gtr:id><gtr:impact>In February 2016 the WHO convened a meeting in Geneva with my team: other attendees (arranged subsequently) were representatives of Jhpiego, The UK Sepsis Trust and the Global Sepsis Alliance. We discussed possibilities for future work to develop a sepsis bundle. Building on our work within the AIMS trial to study maternal infection, we are now preparing a new research plan to find out how a package of simple, reproducible interventions applied consistently in low income settings could identify and treat maternal sepsis more promptly and effectively.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Mixed methods research on reasons for trial participation - AIMS</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>34FA1C65-10E2-441C-B64C-E69CA7D0C6FD</gtr:id><gtr:impact>We are undertaking mixed methods research to find out: factors influencing Malawian women's decisions of whether to participate in a reproductive health clinical trial; women's understanding of reproductive health trial information; the availability, utilisation and quality of miscarriage care services in Blantyre district; healthcare providers' knowledge and practice of miscarriage care; and treatment seeking behaviours and other determinants of access to care.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013,2014,2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sabbatical Activities - AIMS</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>FB27401E-53DC-4DD2-BADF-10DCE464F8E9</gtr:id><gtr:impact>During 2015 I spent three months in Africa: this sabbatical period enabled me to visit AIMS locations to build new connections and renew old friendships with a view to ongoing research collaborations.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Study participants or study members</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Facebook - AIMS</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C81C6BF3-E6C7-420A-9CBC-9D75BE177F5F</gtr:id><gtr:impact>AIMS news is reported via facebook.

The AIMS Trial has gained 67 'Likes' from assorted participants in the research and other supporters.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.facebook.com/aimstrial</gtr:url><gtr:year>2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to the Department of Obstetrics &amp; Gynaecology and Society of Obstetrics &amp; Gynaecology Pakistan (SOGP)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DC9C92DA-EDE0-4FF3-8FD7-0F131669C1C3</gtr:id><gtr:impact>I presented a lecture entitled &amp;quot;Recurrent Miscarriage and Sepsis in Obstetrics and Gynaecology&amp;quot; whilst visiting Aga Khan University.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Peer Support Group - AIMS</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>6DC7D117-D52B-43B7-B089-0F2B01BC7379</gtr:id><gtr:impact>From feedback from the recruiting site in Malawi, we initiated a peer support group for women who have experienced a pregnancy loss, and for teenage mothers. Meetings are held every 3 months. Women often attend multiple meetings and verbal feedback has been very positive. We are exploring possibilities to introduce similar groups at other centres.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Study participants or study members</gtr:primaryAudience><gtr:year>2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to GVS - AIMS</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EEE8422F-0F27-49B1-AE2F-504B8D6A1F83</gtr:id><gtr:impact>40 members of the Gynaecological Visiting Society attended a talk and watched a video about the AIMS project.

Conference delegates were moved by reports of the conditions of maternal healthcare in low income countries, and commented on the importance of projects such as AIMS.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Miscarriage Association - AIMS</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5777D4D3-AE9C-4980-BAF7-69EB930E5C99</gtr:id><gtr:impact>A representative of the Miscarriage Association - who participates in meetings of the AIMS Trial Steering Committee - regularly reports our news of the project via the Miscarriage Association website and meetings of this organisation.

The Miscarriage Association brings news of the AIMS Trial to the public.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.miscarriageassociation.org.uk/</gtr:url><gtr:year>2013,2014,2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Think Corner 2014 - AIMS</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>0AEA9108-A80D-4495-8C7D-9C905FD30343</gtr:id><gtr:impact>On Wednesday 27 August 2014 the AIMS trial participated in the Think Corner, a public engagement pop-up shop in the city centre for the University of Birmingham. We explained the necessity and importance of clinical trials, and asked the children of Birmingham what they thought of research.

Children told us that research is important because...
... it helps to understand the world we live in, how we live in it and make new discoveries that enable us to develop new technologies that improve our lives.
... it's fun.
... we learn new things and develop our world.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.birmingham.ac.uk/news/latest/2014/08/pop-up-shop-20-08-14.aspx</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Website - AIMS</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9CC32358-7C9B-4966-8E6E-7D56CE7110A3</gtr:id><gtr:impact>The AIMS study maintains an active website.

Participants, collaborators and supporters of the AIMS Trial and any other interested members of the public are able to verify the details of the project easily at any time.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.aimstrial.org</gtr:url><gtr:year>2014,2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Community Sensitisation - AIMS Uganda</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>32A89BF4-50E0-4EDE-94D6-6F1F11397AFE</gtr:id><gtr:impact>Antibiotic administration is an issue in Uganda so we designed lay materials for distribution from ten rural health centres, to discuss appropriate use of antibiotics and inform local communities about antibiotic resistance. The materials sparked interest and questions from the women attending each clinic.

Women became interested in ourt study, and in learning how to better combat antibiotic resistance and improve maternal health.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visit to Malawi 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F299FE70-75B6-4F7C-BAE8-64872607DFF0</gtr:id><gtr:impact>I visited AIMS sites in Malawi to speak to peer support groups about the impact of miscarriage in early pregnancy and early age pregnancy. I also held discussions about future collaboration opportunities with organisations such as World Sepsis Alliance, Save the Children and WHO.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Study participants or study members</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Clinical Trials Presentation at IMSR Away Day 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>23004FCA-A9DF-47C2-ABA4-63C242AF9FA7</gtr:id><gtr:impact>I was invited to deliver a presentation entitled &amp;quot;Translating Science into Health - Clinical Trials&amp;quot; to the Institute of Metabolism and Systems Research (IMSR) at the University of Birmingham. Questions and discussions increased awareness and interest in the subject.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Twitter - AIMS</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CFD68DDA-1AC2-40E8-9A83-1812C86B5AA9</gtr:id><gtr:impact>Regular tweets keep the AIMS community abreast of project progress and signpost supporters to topical resources in the field of global women's health. This engagement builds the morale of participants and staff, and the interest of other stakeholders and donors.

This engagement builds the morale of participants and builds the interest of supporters in the AIMS project.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2013,2014,2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visit to Aga Khan University and other sites in Pakistan to review the progress of the AIMS trial</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>65B5BE22-0B43-481A-80E6-EA13D4A95814</gtr:id><gtr:impact>I held a series of site visits and other meetings at Aga Khan University, Pakistan to discuss the ongoing progress of the AIMS trial with healthcare professionals and data managers.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>12000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Maternal Sepsis (Ammalife)</gtr:description><gtr:end>2018-04-02</gtr:end><gtr:fundingOrg>Ammalife</gtr:fundingOrg><gtr:id>061D009F-7913-435A-8FE3-6D3EEA6E56DA</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MSD for Mothers - Maternal Sepsis</gtr:description><gtr:end>2020-02-02</gtr:end><gtr:fundingOrg>Merck &amp; Co. Inc. (MSD)</gtr:fundingOrg><gtr:id>2870293F-2B76-4781-AB9A-5D2B91B39E74</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2017-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>2015 Maternal Sepsis (DARO)</gtr:description><gtr:fundingOrg>University of Birmingham</gtr:fundingOrg><gtr:id>82030BCF-3557-4FA8-9ED1-0422C58352A6</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>The AIMS (Antibiotics in Miscarriage Surgery) project proposes that antibiotics given just before miscarriage surgery could reduce the chances of infection, and tests the hypothesis through a large clinical trial in Malawi, Tanzania, Uganda and Pakistan. The study is endorsed by the WHO, FIGO and RCOG, and financially supported by the MRC, Wellcome Trust and UK Department for International Development.</gtr:description><gtr:id>5977AD7A-00E9-4D21-BD76-BDCD38D4DCE8</gtr:id><gtr:impact>Please refer to other sections of the portfolio for further details.</gtr:impact><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Antibiotics in miscarriage surgery</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:url>http://www.ammalife.org/research/aims-antibiotics-in-miscarriage-surgery</gtr:url><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F9177772-2066-4EE9-A770-6A05D12C8048"><gtr:id>F9177772-2066-4EE9-A770-6A05D12C8048</gtr:id><gtr:title>The Global Maternal and Neonatal Sepsis Initiative: a call for collaboration and action by 2030.</gtr:title><gtr:parentPublicationTitle>The Lancet. Global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f3a46fd35780f13acdfbb0a3ca6c2760"><gtr:id>f3a46fd35780f13acdfbb0a3ca6c2760</gtr:id><gtr:otherNames>Global Maternal and Neonatal Sepsis Initiative Working Group. Electronic address: bonetm@who.int</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2214-109X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/248DA34E-DE53-494E-B398-47CAB637195F"><gtr:id>248DA34E-DE53-494E-B398-47CAB637195F</gtr:id><gtr:title>A mixed-methods study of barriers and facilitators to the implementation of postpartum hemorrhage guidelines in Uganda.</gtr:title><gtr:parentPublicationTitle>International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9803866ba3a8a9ad5091f1fc89ac868c"><gtr:id>9803866ba3a8a9ad5091f1fc89ac868c</gtr:id><gtr:otherNames>Braddick L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0020-7292</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A195DF27-C64A-4B57-9ADB-EB1D94599DC1"><gtr:id>A195DF27-C64A-4B57-9ADB-EB1D94599DC1</gtr:id><gtr:title>Zika virus and pregnancy.</gtr:title><gtr:parentPublicationTitle>BJOG : an international journal of obstetrics and gynaecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2c8d213937d9bd1b0048c2eba50d0098"><gtr:id>2c8d213937d9bd1b0048c2eba50d0098</gtr:id><gtr:otherNames>Lissauer D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1470-0328</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/K007408/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>FA7AA693-7EDD-4A7E-8CA3-6B5658FBF717</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Reproductive Health and Childbirth</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>